264 related articles for article (PubMed ID: 7759846)
1. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
[TBL] [Abstract][Full Text] [Related]
2. [Left ventricular performance and morphologic myocardial changes in untreated hypertensive patients].
du Cailar G; Ribstein J; Radauceanu A; Halimi JM; Mimran A
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):1011-4. PubMed ID: 7755449
[TBL] [Abstract][Full Text] [Related]
3. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
4. [Relation between left ventricular hypertrophy and retinal vascular changes in mild hypertension].
Pose Reino A; González-Juanatey JR; Castroviejo M; Valdés L; Estévez JC; Méndez I; Cabezas-Cerrato J
Med Clin (Barc); 1997 Mar; 108(8):281-5. PubMed ID: 9121203
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
Díez J; Laviades C
J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
[TBL] [Abstract][Full Text] [Related]
7. Vascular permeability, blood pressure, and organ damage in primary hypertension.
Viazzi F; Leoncini G; Ratto E; Parodi A; Falqui V; Conti N; Tomolillo C; Ravera G; Deferrari G; Pontremoli R
Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
[TBL] [Abstract][Full Text] [Related]
8. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
[TBL] [Abstract][Full Text] [Related]
9. Is retinal arteriolar-venular ratio associated with cardiac and extracardiac organ damage in essential hypertension?
Masaidi M; Cuspidi C; Giudici V; Negri F; Sala C; Zanchetti A; Grassi G; Mancia G
J Hypertens; 2009 Jun; 27(6):1277-83. PubMed ID: 19357533
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular geometry as an independent predictor for extracardiac target organ damage in essential hypertension.
Shigematsu Y; Hamada M; Ohtsuka T; Hashida H; Ikeda S; Kuwahara T; Hara Y; Kodama K; Hiwada K
Am J Hypertens; 1998 Oct; 11(10):1171-7. PubMed ID: 9799033
[TBL] [Abstract][Full Text] [Related]
11. Influence of metabolic syndrome on hypertension-related target organ damage.
Mulè G; Nardi E; Cottone S; Cusimano P; Volpe V; Piazza G; Mongiovì R; Mezzatesta G; Andronico G; Cerasola G
J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
[TBL] [Abstract][Full Text] [Related]
12. Association between left ventricular hypertrophy with retinopathy and renal dysfunction in patients with essential hypertension.
Shirafkan A; Motahari M; Mojerlou M; Rezghi Z; Behnampour N; Gholamrezanezhad A
Singapore Med J; 2009 Dec; 50(12):1177-83. PubMed ID: 20087555
[TBL] [Abstract][Full Text] [Related]
13. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
[TBL] [Abstract][Full Text] [Related]
14. Inadequate suppression of angiotensin II modulates left ventricular structure in humans.
Schlaich MP; Schobel HP; Langenfeld MR; Hilgers K; Schmieder RE
Clin Nephrol; 1998 Mar; 49(3):153-9. PubMed ID: 9543596
[TBL] [Abstract][Full Text] [Related]
15. Proportion of isolated clinical hypertension in primary care settings. Comparison of target organ damage in patients with isolated clinical hypertension and patients with sustained arterial hypertension.
Boreu QF; de Tuero GC; Rodríguez-Poncelas A; Albertos MS; Zafra MS; Radó MA;
Blood Press; 2007; 16(6):354-61. PubMed ID: 17852096
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding proteins in arterial hypertension: relationship to left ventricular hypertrophy.
Díez J; Laviades C; Martínez E; Gil MJ; Monreal I; Fernández J; Prieto J
J Hypertens; 1995 Mar; 13(3):349-55. PubMed ID: 7542683
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure load, vascular permeability and target organ damage in primary hypertension.
Falqui V; Viazzi F; Leoncini G; Ratto E; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
J Nephrol; 2007; 20 Suppl 12():S63-7. PubMed ID: 18050146
[TBL] [Abstract][Full Text] [Related]
19. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism.
Shigematsu Y; Hamada M; Okayama H; Hara Y; Hayashi Y; Kodama K; Kohara K; Hiwada K
Hypertension; 1997 Mar; 29(3):723-7. PubMed ID: 9052887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
